Financial Metrics Check: Akero Therapeutics Inc (AKRO)’s Ratios for Trailing Twelve Months

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

As of close of business last night, Akero Therapeutics Inc’s stock clocked out at $23.20, up 6.52% from its previous closing price of $21.78. In other words, the price has increased by $6.52 from its previous closing price. On the day, 2.54 million shares were traded. AKRO stock price reached its highest trading level at $23.56 during the session, while it also had its lowest trading level at $21.88.


To gain a deeper understanding of AKRO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 30.12 and its Current Ratio is at 30.12. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.

On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.

On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.UBS initiated its Buy rating on August 28, 2023, with a $83 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 11 ’24 when Cheng Andrew sold 7,894 shares for $22.64 per share. The transaction valued at 178,728 led to the insider holds 581,553 shares of the business.

White William Richard sold 2,831 shares of AKRO for $64,094 on Jun 11 ’24. The Chief Financial Officer now owns 46,799 shares after completing the transaction at $22.64 per share. On Jun 11 ’24, another insider, Yale Catriona, who serves as the Chief Development Officer of the company, sold 2,825 shares for $22.64 each. As a result, the insider received 63,961 and left with 74,867 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1604303232 and an Enterprise Value of 736458368.

Stock Price History:

Over the past 52 weeks, AKRO has reached a high of $54.35, while it has fallen to a 52-week low of $11.25. The 50-Day Moving Average of the stock is 11.18%, while the 200-Day Moving Average is calculated to be -4.31%.

Shares Statistics:

It appears that AKRO traded 758.42K shares on average per day over the past three months and 1029620 shares per day over the past ten days. A total of 69.15M shares are outstanding, with a floating share count of 57.87M. Insiders hold about 16.31% of the company’s shares, while institutions hold 99.13% stake in the company. Shares short for AKRO as of 1715731200 were 8327255 with a Short Ratio of 9.83, compared to 1713139200 on 8183677. Therefore, it implies a Short% of Shares Outstanding of 8327255 and a Short% of Float of 12.4.

Most Popular